Trial Profile
A phase I study investigating the effect of ABT-751 given in combination with capecitabine, irinotecan and bevacizumab in advanced colorectal cancer patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs ABT 751 (Primary) ; Bevacizumab; Capecitabine; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics
- 12 Dec 2015 New trial record
- 03 Dec 2015 Results published in the Journal of Clinical Pharmacology